Denali Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $429k | 21k | 20.38 |
| 2024-09-30 | $896k | 31k | 29.13 |
| 2024-03-31 | $45k | 75k | 0.60 |
| 2023-09-30 | $1.2M | 59k | 20.63 |
| 2023-06-30 | $1.4M | 49k | 29.51 |
| 2020-03-31 | $651k | 37k | 17.50 |